709 related articles for article (PubMed ID: 27060725)
1. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
[TBL] [Abstract][Full Text] [Related]
3. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
4. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors.
Trinh TD; Zasowski EJ; Claeys KC; Lagnf AM; Kidambi S; Davis SL; Rybak MJ
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):61-66. PubMed ID: 28716451
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.
Sibila O; Laserna E; Maselli DJ; Fernandez JF; Mortensen EM; Anzueto A; Waterer G; Restrepo MI
Respirology; 2015 May; 20(4):660-6. PubMed ID: 25776134
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital.
Koh SJ; Lee JH
Korean J Intern Med; 2015 Sep; 30(5):638-47. PubMed ID: 26354058
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis.
Arancibia F; Bauer TT; Ewig S; Mensa J; Gonzalez J; Niederman MS; Torres A
Arch Intern Med; 2002 Sep; 162(16):1849-58. PubMed ID: 12196083
[TBL] [Abstract][Full Text] [Related]
9. Community-acquired pneumonia with risk for drug-resistant pathogens.
Fleming V; Buck B; Nix N; Kumar P; Southwood R
South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).
Fukuyama H; Yamashiro S; Tamaki H; Kishaba T
J Infect Chemother; 2013 Aug; 19(4):719-26. PubMed ID: 23354936
[TBL] [Abstract][Full Text] [Related]
11. A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
Maruyama T; Fujisawa T; Ishida T; Ito A; Oyamada Y; Fujimoto K; Yoshida M; Maeda H; Miyashita N; Nagai H; Imamura Y; Shime N; Suzuki S; Amishima M; Higa F; Kobayashi H; Suga S; Tsutsui K; Kohno S; Brito V; Niederman MS
Clin Infect Dis; 2019 Mar; 68(7):1080-1088. PubMed ID: 30084884
[TBL] [Abstract][Full Text] [Related]
12. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
13. Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.
Laserna E; Sibila O; Fernandez JF; Maselli DJ; Mortensen EM; Anzueto A; Waterer G; Restrepo MI
Chest; 2014 May; 145(5):1114-1120. PubMed ID: 24458223
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
[TBL] [Abstract][Full Text] [Related]
15. Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.
Joo EJ; Kang CI; Ha YE; Park SY; Kang SJ; Wi YM; Lee NY; Chung DR; Peck KR; Song JH
Infection; 2011 Aug; 39(4):309-18. PubMed ID: 21594653
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia.
Kang YS; Ryoo SR; Byun SJ; Jeong YJ; Oh JY; Yoon YS
Yonsei Med J; 2017 Jan; 58(1):180-186. PubMed ID: 27873512
[TBL] [Abstract][Full Text] [Related]
17. Should nursing home-acquired pneumonia be treated as nosocomial pneumonia?
Ma HM; Wah JL; Woo J
J Am Med Dir Assoc; 2012 Oct; 13(8):727-31. PubMed ID: 22889729
[TBL] [Abstract][Full Text] [Related]
18. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
[TBL] [Abstract][Full Text] [Related]
19. Demographics and microbiological profile of pneumonia in United Arab Emirates.
Al-Muhairi S; Zoubeidi T; Ellis M; Nicholls MG; Safa W; Joseph J
Monaldi Arch Chest Dis; 2006 Mar; 65(1):13-8. PubMed ID: 16700188
[TBL] [Abstract][Full Text] [Related]
20. Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
Idigo AJ; Wells JM; Brown ML; Wiener HW; Griffin RL; Cutter G; Shrestha S; Lee RA
Antimicrob Resist Infect Control; 2022 Jul; 11(1):95. PubMed ID: 35836272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
